Immune Inflammatory Markers
Immune Inflammatory Markers - Related Videos
01:38
What is the Immune System?
0 Views •
2019
Overview The immune system comprises diverse biological structures and processes that protect the body from disease. These processes can be classified into innate and adaptive immunity. To work effectively, the immune system needs to detect pathogens by distinguishing the body’s own structures from foreign elements. If this determination fails, autoimmune diseases occur in which the immune system reacts against the body’s own tissue. The Innate Immune System Acts Fast and Non-specifically
03:45
Quantification of Inflammatory Mediators in Infected Human Tissue-Derived Cells
0 Views •
2025
This video demonstrates the quantification of inflammatory mediators during infection by incubating human lung-tissue-derived immune cells with Haemophilus influenzae. Flow cytometry is used to measure cytokine fluorescence in labeled lymphocytes, correlating with the production of pro-inflammatory cytokines in response to bacterial infection.
09:40
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
0 Views •
Cited by 2 •
2024
Tropomodulin 3 (TMOD3) has been increasingly studied in tumors in recent years. This study is the first to report that TMOD3 is highly expressed in ovarian cancer and is closely associated with platinum resistance and immune infiltration. These results could help improve the therapeutic outcomes for ovarian cancer.
03:44
The Photoconversion Technique for Exploring Inflammatory Cell Dynamics in Insect Pupae
0 Views •
2025
The video demonstrates the use of photoconversion to study inflammatory cell dynamics in Drosophila pupae. Green hemocytes are drawn to the wounded epithelium, followed by distant migration. Photoconversion shifts certain hemocytes from green to red, facilitating their movement tracking.
14:43
Differentiating Functional Roles of Gene Expression from Immune and Non-immune Cells in Mouse Colitis by Bone Marrow Transplantation
0 Views •
Cited by 2 •
2012
Bone marrow transplantation provides a way to change the genotype of the bone marrow derived cells. If the gene of interest is expressed in both bone marrow derived cells and non-bone marrow derived cells, bone marrow transplantation can change the bone marrow derived cells to a different genotype without changing the non-bone marrow derived cell genotype.
FAQs
During infection, injury, or immune dysregulation, activated immune cells release signaling molecules such as cytokines. At the same time, the liver and other tissues can change production of acute-phase proteins, creating measurable shifts in clinical samples. These changes reflect immune activation and tissue response, but their meaning depends on biological context rather than on the marker alone.
An elevated result can occur across infection, injury, autoimmune disease, or other forms of immune dysregulation because these conditions may produce overlapping inflammatory responses. Consequently, C-reactive protein, erythrocyte sedimentation rate, cytokine levels, and leukocyte counts provide supportive evidence rather than a standalone diagnosis. Clinicians need symptoms and other findings to determine what the result means.
They represent different observable aspects of immune activity. C-reactive protein is an acute-phase protein, cytokines are signaling molecules released by activated immune cells, and leukocyte counts reflect cellular changes; erythrocyte sedimentation rate is another clinical marker. Considering these measurements together can provide broader information about disease activity or tissue response, while still requiring clinical interpretation.
Blood is one clinical sample used to assess these markers, although other clinical samples may also be examined. Testing can detect measurable molecules, proteins, or cellular changes, including acute-phase proteins, cytokines, and leukocyte counts. The resulting measurements help characterize immune activity and tissue response within a clinical evaluation.
They can support clinical evaluation of infection, autoimmune disease, and treatment response. They may also help assess disease activity and tissue response when interpreted with symptoms and other findings. Their value is therefore supportive: a marker result can contribute to judging the clinical picture, but it cannot by itself establish a specific disease.
Changes in measured markers can be followed as part of evaluating treatment response because they may reflect altered immune activity or tissue response. However, a change should not be treated as conclusive on its own. Clinicians need to compare it with symptoms and other findings before interpreting the overall response to treatment.